An Engineered Cytidine Deaminase for Biocatalytic Production of a Key Intermediate of the Covid-19 Antiviral Molnupiravir (2021)
Attributed to:
The Royce: Capitalising on the investment
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: Journal of the American Chemical Society